Highlights and Quick Summary
- Gross Profit for the quarter ending September 30, 2023 was $2.53 Million (a 140.65% increase compared to previous quarter)
- Year-over-year quarterly Gross Profit increased by 102.4%
- Annual Gross Profit for 2022 was $8.25 Million (a 27.57% increase from previous year)
- Annual Gross Profit for 2021 was $6.47 Million (a 13.77% increase from previous year)
- Annual Gross Profit for 2020 was $5.69 Million (a 19.61% increase from previous year)
- Twelve month Gross Profit ending September 30, 2023 was $6.12 Million (a -26.47% decrease compared to previous quarter)
- Twelve month trailing Gross Profit decreased by -29.66% year-over-year
Trailing Gross Profit for the last four month:
30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
---|---|---|---|
$6.12 Million | $8.32 Million | $8.88 Million | $8.69 Million |
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Gross Profit of ARAVIVE, INC
Most recent Gross Profitof ARAV including historical data for past 10 years.Interactive Chart of Gross Profit of ARAVIVE, INC
ARAVIVE, INC Gross Profit for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $2.53 | $1.05 | $1.28 | – | – |
2022 | $1.25 | $4.74 | $1.62 | $1.09 | $8.25 |
2021 | $0.99 | $2.41 | $3.79 | $0.26 | $6.47 |
2020 | – | $-0.45 | $-1.03 | $-0.13 | $5.69 |
2019 | – | $0.0 | $3.05 | $1.7 | $4.75 |
2018 | – | – | – | – | $1.37 |
2017 | – | – | – | – | $40.0 |
2016 | – | – | – | – | $-0.22 |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology